Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates

Biochemical and Biophysical Research Communications

Volumn 305, Issue 4, 2003, Pages 909-914

  Ho, Y T ^a   Purohit, A ^a   Vicker, N ^b   Newman, S P ^a   Robinson, J J ^b   Leese, M P ^b   Ganeshapillai, D ^b   Woo, L W L ^b   Potter, B V L ^b   Reed, M J ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BATH   (United Kingdom)

Author keywords

Acetazolamide; Cancer; Carbonic anhydrase; Oestrone sulphamate; Steroid sulphatase

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE II; ENZYME INHIBITOR; STERYL SULFATASE;

ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYSTAL STRUCTURE; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG INHIBITION; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; OBSERVATION; PRIORITY JOURNAL; PROTEIN DOMAIN; TUMOR CELL;

EID: 0037904915     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00865-9     Document Type: Article

References (45)

1. Sly W.S., Hu P.Y. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu. Rev. Biochem. 64:1995;375-401.
2. McKierman J.M., Buttyan R., Stifelman M.D.et al. Expression of tumor-associated gene MN: a potential biomarker of human renal cell carcinoma. Cancer Res. 57:1997;2362-2365.
3. Tureci O., Sahin U., Vollmar E.et al. Human carbonic anhydrase XII: cDNA cloning, expression and chromosomal localization of a carbonic anhydrase gene that is over expressed in some renal cancers. Proc. Natl. Acad. Sci. USA. 95:1998;7608-7613.
4. Chegwidden W.R., Spencer I.M. Sulphonamide inhibitors of carbonic anhydrase inhibit the growth of human lymphoma cells in culture. Inflammopharmacology. 3:1995;231-239.
5. Ivanov S.V., Kuzmin I., Wei M.-H.et al. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc. Natl. Acad. Sci. USA. 95:1998;12596-12601.
6. Wykoff C.C., Beasley N.J.P., Watson P.H.et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 60:2000;7075-7083.
7. Loncaster J.A., Harris A.L., Davison S.E.et al. Carbonic anhydrase IX expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. 61:2001;6394-6399.
8. Knowles H.J., Harris A.L. Hypoxia and oxidative stress in breast cancer. Breast Cancer Res. 3:2001;318-322.
9. Harris A.L. Hypoxia - a key regulatory factor in tumour growth. Nat. Cancer Rev. 2:2001;38-47.
10. Parkkila S., Rajaniemi H., Parkkila A.-K.et al. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc. Natl. Acad. Sci. USA. 97:2000;2220-2224.
11. Teicher B.A., Liu S.-D., Liu J.-T.et al. A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. AntiCancer Res. 13:1993;1549-1556.
12. Supuran C.T., Scozzafava A. Carbonic anhydrase inhibitors and their therapeutic potential. Exp. Opin. Ther. Patents. 10:2000;575-600.
13. Supuran C.T., Briganit F., Tilli S.et al. Carbonic anhydrase inhibitors: sulfonamides as antitumor agents? Bioorg. Med. Chem. 9:2001;703-714.
14. Reed M.J., Purohit A., Howarth N.M., Potter B.V.L. Steroid sulphatase inhibitors: a new endocrine therapy. Drugs of the Future. 19:1994;673-680.
15. Vicker N., Ho Y.T., Robinson J.et al. Docking studies of sulphamate inhibitors of estrone sulphatase in human carbonic anhydrase II. Bioorg. Med. Chem. Lett. 13:2003;863-865.
16. Elger W., Schwarz S., Hedden A.et al. Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application. J. Steroid Biochem. Mol. Biol. 55:1995;395-403.
17. Elger W., Palme H.-J., Schwarz S. Novel oestrogen sulphamates: a new approach to oral hormone therapy. Exp. Opin. Invest. Drugs. 7:1998;575-589.
18. Purohit A., Williams G.J., Howarth N.M.et al. In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate. Int. J. Cancer. 62:1995;106-111.
19. Pastorek J., Pastorekova S., Callebaut I.et al. Cloning and characterisation of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase as a putative helix-loop-helix DNA binding segment. Oncogene. 9:1994;2877-2888.
20. Pastorekova S., Parkkila S., Parkkila A.K.et al. Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. Gastroenterology. 112:1997;398-408.
21. R.M. Torczynski, A.P. Bollin, Gene sequence and probe for a markar of non-small cell lung carcinoma, US Patent 5,589,579, 1996.
22. Zavada J., Zavadova Z., Pastorekova S.et al. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int. J. Cancer. 54:1993;268-274.
23. Armstrong J.M., Myers D.V., Verpoorte I.A.et al. Purification and properties of human erthyrocyte carbonic anhydrases. J. Biol. Chem. 241:1966;5137-5149.
24. Berman H.M., Westbrook J., Feng Z.et al. The Protein Data Bank. Nucleic Acids Res. 28:2000;235-242.
25. Hakansson K., Carlsson M., Svensson L.A.et al. Structure of native and apo carbonic anhydrase II and some of its anion-ligand complexes. J. Mol. Biol. 227:1992;1192-1204.
26. Whittington D.A., Waheed A., Ulmasou B.et al. Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein over expressed in certain cancer tumor cells. Proc. Soc. Natl. Acad. Sci. USA. 98:2001;9545-9550.
27. Sybyl 6.8 Tripos, Inc., St. Louis, 170, 2000.
28. Halgren T.A. Merck molecular force field I. Basis, form, scope, parameterization, and performance with MMFF94. J. Comput. Chem. 17:1996;490-519.
29. Rarey M., Kramer B., Laugenauer T.et al. A fast flexible docking method using an incremental construction algorithm. J. Mol. Biol. 261:1996;470-489.
30. MOE - Molecular Operating Environment, Chemical Computing Group Inc., Quebec, Canada.
31. Jones G., Willet P., Glen R.C. Molecular recognition of a receptor sites using a genetic algorithm with a description of desolvation. J. Mol. Biol. 245:1995;43-53.
32. Jones G., Willet P., Glen R.C.et al. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 267:1997;727-748.
33. Woo L.W.L., Purohit A., Malini B.et al. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates. Chem. Biol. 7:2000;773-791.
34. Landolfi C., Marchetti M., Ciocci G.et al. Milanese, Development and pharmacological characterization of a modified procedure for the measurement of carbonic anhydrase activity. Anal. Biochem. 185:1990;254-264.
35. Supuran C.T., Scozzafava A. Carbonic anhydrase inhibitors. Med. Res. Rev. 23:2003;146-189.
36. Li P.-K., Pillai R., Young B.L.et al. Synthesis and biochemical studies of estrone sulphatase inhibitors. Steroids. 58:1993;106-111.
37. D. Ganeshapillai, The synthesis of novel anticancer agents with therapeutic potential, University of Bath, Ph.D. thesis, 2002.
38. Owa T., Yoshino H., Okauchi T.et al. Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle. J. Med. Chem. 42:1999;3789-3799.
39. Supuran C.T. Indisulam - an anticancer sulfonamide in clinical development. Exp. Opin. Invest. Drugs. 12:2003;283-287.
40. Duncan L.J., Purohit A., Howarth N.M.et al. Inhibition of estrone sulfatase activity by estrone-3-methylethiophosphonate: a potential therapeutic agent in breast cancer. Cancer Res. 53:1993;298-303.
41. Casini A., Antel J., Abbate F.et al. Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulphamides with isoenzymes I, II and IV. Bioorg. Med. Lett. 13:2003;841-845.
42. Reed M.J., Purohit A., Woo L.W.L.et al. The development of steroid sulphatase inhibitors. Endocr. Relat. Cancer. 3:1996;9-23.
43. Scozzafava A., Briganti F., Ilies M.A.et al. Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes. J. Med. Chem. 43:2000;292-300.
44. Vullo D., Franchi M., Gallori E.et al. Bioorg. Med. Lett. 13:2003;1005-1009.
45. Jain A.N. Surflex: Fully automated flexible molecular docking using a molecular similarity-based search engine. J. Med. Chem. 46:2003;499-511.